ML753286 is a potent inhibitor for BCRP, ML753286 has low to medium clearance in rodent and human liver S9 fractions, and is stable in plasma cross species. B References: Shi P, Liao M, Chuang BC, Griffin R, Shi J, Hyer M, Fallon JK, Smith PC, Li C, Xia CQ. Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug-drug interaction profiles. Xenobiotica. 2017 Nov 16:1-11. doi: 10.1080/00498254.2017.1397812. [Epub ahead of print] PubMed PMID: 29098941.

纯度：≥98%

CAS：1699720-89-2